Inspire Investing’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$679K Sell
11,555
-4,371
-27% -$183K 0.03% 750
2026
Q1
$513K Buy
15,926
+4,871
+44% +$180K 0.03% 729
2025
Q4
$465K Sell
11,055
-2,078
-16% -$83.8K 0.04% 670
2025
Q3
$451K Sell
13,133
-1,291
-9% -$37K 0.04% 703
2025
Q2
$390K Buy
14,424
+2,833
+24% +$82.1K 0.04% 530
2025
Q1
$344K Buy
11,591
+1,506
+15% +$57.4K 0.04% 557
2024
Q4
$399K Sell
10,085
-1,997
-17% -$75.6K 0.04% 670
2024
Q3
$411K Sell
12,082
-4,380
-27% -$123K 0.04% 638
2024
Q2
$357K Buy
16,462
+340
+2% +$7.15K 0.04% 380
2024
Q1
$357K Buy
16,122
+2,139
+15% +$52.2K 0.04% 685
2023
Q4
$385K Buy
13,983
+246
+2% +$5.94K 0.04% 497
2023
Q3
$307K Buy
+13,737
New +$353K 0.04% 573

Other funds holding VCYT

Inspire Investing's VCYT Position: Q2 2026 in Review

Inspire Investing reduced its Veracyte (VCYT) stake by 27% in Q2 2026, selling an estimated $183K and leaving 11,555 shares worth $679K. The position accounts for 0.03% of the portfolio, ranked #750.

Inspire Investing first reported a position in VCYT in Q3 2023 and has held it in 12 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Inspire Investing held 11,555 shares of Veracyte worth $679K as of Q2 2026.
  • Inspire Investing sold 4,371 Veracyte shares in Q2 2026, an estimated $183K.
  • Veracyte made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #750 holding.
  • Inspire Investing first reported a position in Veracyte in Q3 2023 and has held it in 12 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.